AGC Biologics Invests in New Viral Vector Suspension Capabilities at U.S. Cell & Gene Hub, Business News

SEATTLE, May 17, 2022 (GLOBE NEWSWIRE) — AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced it is adding viral vector suspension technology and capacity for the…